我国对全球糖尿病防控做出贡献的十大临床研究  

Ten clinical studies in China contributing to the global research on prevention and control of diabetes mellitus

作　　者：高蕾莉[1] 纪立农[1] GAO LeiLi;JI LiNong(Department of Endocrinology,Peking University People＇s Hospital,Beijing 100044,China)

机构地区：[1]北京大学人民医院内分泌科,北京100044

出　　处：《中国科学：生命科学》2018年第8期827-833,共7页Scientia Sinica(Vitae)

摘　　要：目前糖尿病患病率呈飞速增长的趋势.对于未发生糖尿病的人群如何有效预防糖尿病的发生成为中国和全球面临的重要课题.对于已经确诊糖尿病的患者,有效控制血糖、降低糖尿病相关并发症尤其是心血管疾病的发生风险成为糖尿病治疗的关键.近年来,我国研究者针对糖尿病前期人群和糖尿病人群开展了系列研究,为糖尿病的预防、血糖控制及并发症防治提供了丰富的循证医学证据,为中国及全球的糖尿病防控做出了积极的贡献.Prevalence of diabetes mellitus is rapidly increasing in China. Effective prevention of diabetes has become an important medical issue worldwide, including in China. Treatment of diabetic patients primarily includes effectively controlling blood glucose and reducing the risk of diabetes-related complications, particularly cardiovascular diseases. In recent years, Chinese researchers performed a series of studies in the pre-diabetic and diabetic population. These clinical studies provided abundant medical evidences for the prevention and control of diabetes and its complications. In this study, we present the positive contribution of these studies to the prevention and control of diabetes in China and worldwide.

关 键 词：糖尿病 预防 控制 并发症 中国 

分 类 号：R587.1[医药卫生—内分泌]